New Biological Therapies for Low-Density Lipoprotein Cholesterol
Canadian Journal of Cardiology · 2023
DOI: 10.1016/j.cjca.2023.08.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Cardiology, 2023. Verfasst von Praneet K Gill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis, Vaccines, Anticholesteremic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 126 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
- Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Electronic address: hegele@robarts.ca.
Zitieren
APA
Gill, P. K., & Hegele, R. A. (2023). New Biological Therapies for Low-Density Lipoprotein Cholesterol. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2023.08.003
Vancouver
Gill PK, Hegele RA. New Biological Therapies for Low-Density Lipoprotein Cholesterol. Canadian Journal of Cardiology. 2023. doi:10.1016/j.cjca.2023.08.003
BibTeX
@article{Gill2023,
author = {Gill, Praneet K and Hegele, Robert A},
title = {New Biological Therapies for Low-Density Lipoprotein Cholesterol},
journal = {Canadian Journal of Cardiology},
year = {2023},
doi = {10.1016/j.cjca.2023.08.003}
}
EUVIMED